In addition, CHD4 knockdown increased the chemosensitivity of breast cancer cells towards cisplatin[94] and increased the sensitivity of hepatocellular carcinoma cells towards epirubicin, an antitumor antibiotic[44]. This evidence concerns the gene CHD4 and breast cancer.